{"title":"盆腔癌放疗后肠道菌群的改变","authors":"Lyu-Han Wang, J. Qian","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.11.006","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the effect of pelvic radiotherapy on intestinal flora, the correlation between radiation enteritis and intestinal flora, and the effect of probiotics intervention on intestinal flora and diarrhea. \n \n \nMethods \nFrom March to November 2018, a total of 22 patients who were admitted to the Affiliated Suzhou Hospital of Nanjing Medical University were enrolled in the study, including 5 patients with colorectal cancer, 15 patients with cervical cancer and 2 patients with endometrial carcinoma. Five patients with cervical cancer received oral administration of probiotics combined with radiotherapy. Ten healthy physical examiners were selected as the control group. The stool samples were collected from each patient before and after radiotherapy, and 16S rDNA sequencing technology was used to detect the fecal flora and analyze the effect of radiotherapy on intestinal flora. \n \n \nResults \nThe main composition of intestinal flora in the stool samples of healthy control group was Firmicutes (39.86%), Bacteroidetes (37.77%), unclassified bacteria (15.96%) and Proteobacteria (5.03%), which was similar to patients, but the abundance of bacteria was significantly different. There were differences in the intestinal flora of patients before and after radiotherapy. Microbial diversity and abundance were altered after radiotherapy, especially in patients who later developed severe diarrhea. The Firmicutes/Bacteroidetes ratio was altered after radiotherapy. The abundance of Escherichia-Shigella and Fusobacterium increased after radiotherapy in patients who developed severe diarrhea. Oral administration of probiotics could alleviate the diarrhea and reduce the decline of microbial diversity and abundance. \n \n \nConclusions \nIn patients with pelvic tumors, the diversity and abundance of intestinal flora decrease after radiotherapy, especially in patients with severe diarrhea. Oral probiotics can alleviate the diarrhea. \n \n \nKey words: \nPelvic neoplasms; Radiation enteritis; 16S rDNA; Intestinal flora; Probiotics","PeriodicalId":9505,"journal":{"name":"肿瘤研究与临床","volume":"31 1","pages":"744-750"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Alteration of intestinal flora after radiotherapy in patients with pelvic cancer\",\"authors\":\"Lyu-Han Wang, J. Qian\",\"doi\":\"10.3760/CMA.J.ISSN.1006-9801.2019.11.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo investigate the effect of pelvic radiotherapy on intestinal flora, the correlation between radiation enteritis and intestinal flora, and the effect of probiotics intervention on intestinal flora and diarrhea. \\n \\n \\nMethods \\nFrom March to November 2018, a total of 22 patients who were admitted to the Affiliated Suzhou Hospital of Nanjing Medical University were enrolled in the study, including 5 patients with colorectal cancer, 15 patients with cervical cancer and 2 patients with endometrial carcinoma. Five patients with cervical cancer received oral administration of probiotics combined with radiotherapy. Ten healthy physical examiners were selected as the control group. The stool samples were collected from each patient before and after radiotherapy, and 16S rDNA sequencing technology was used to detect the fecal flora and analyze the effect of radiotherapy on intestinal flora. \\n \\n \\nResults \\nThe main composition of intestinal flora in the stool samples of healthy control group was Firmicutes (39.86%), Bacteroidetes (37.77%), unclassified bacteria (15.96%) and Proteobacteria (5.03%), which was similar to patients, but the abundance of bacteria was significantly different. There were differences in the intestinal flora of patients before and after radiotherapy. Microbial diversity and abundance were altered after radiotherapy, especially in patients who later developed severe diarrhea. The Firmicutes/Bacteroidetes ratio was altered after radiotherapy. The abundance of Escherichia-Shigella and Fusobacterium increased after radiotherapy in patients who developed severe diarrhea. Oral administration of probiotics could alleviate the diarrhea and reduce the decline of microbial diversity and abundance. \\n \\n \\nConclusions \\nIn patients with pelvic tumors, the diversity and abundance of intestinal flora decrease after radiotherapy, especially in patients with severe diarrhea. Oral probiotics can alleviate the diarrhea. \\n \\n \\nKey words: \\nPelvic neoplasms; Radiation enteritis; 16S rDNA; Intestinal flora; Probiotics\",\"PeriodicalId\":9505,\"journal\":{\"name\":\"肿瘤研究与临床\",\"volume\":\"31 1\",\"pages\":\"744-750\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"肿瘤研究与临床\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"肿瘤研究与临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.11.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Alteration of intestinal flora after radiotherapy in patients with pelvic cancer
Objective
To investigate the effect of pelvic radiotherapy on intestinal flora, the correlation between radiation enteritis and intestinal flora, and the effect of probiotics intervention on intestinal flora and diarrhea.
Methods
From March to November 2018, a total of 22 patients who were admitted to the Affiliated Suzhou Hospital of Nanjing Medical University were enrolled in the study, including 5 patients with colorectal cancer, 15 patients with cervical cancer and 2 patients with endometrial carcinoma. Five patients with cervical cancer received oral administration of probiotics combined with radiotherapy. Ten healthy physical examiners were selected as the control group. The stool samples were collected from each patient before and after radiotherapy, and 16S rDNA sequencing technology was used to detect the fecal flora and analyze the effect of radiotherapy on intestinal flora.
Results
The main composition of intestinal flora in the stool samples of healthy control group was Firmicutes (39.86%), Bacteroidetes (37.77%), unclassified bacteria (15.96%) and Proteobacteria (5.03%), which was similar to patients, but the abundance of bacteria was significantly different. There were differences in the intestinal flora of patients before and after radiotherapy. Microbial diversity and abundance were altered after radiotherapy, especially in patients who later developed severe diarrhea. The Firmicutes/Bacteroidetes ratio was altered after radiotherapy. The abundance of Escherichia-Shigella and Fusobacterium increased after radiotherapy in patients who developed severe diarrhea. Oral administration of probiotics could alleviate the diarrhea and reduce the decline of microbial diversity and abundance.
Conclusions
In patients with pelvic tumors, the diversity and abundance of intestinal flora decrease after radiotherapy, especially in patients with severe diarrhea. Oral probiotics can alleviate the diarrhea.
Key words:
Pelvic neoplasms; Radiation enteritis; 16S rDNA; Intestinal flora; Probiotics
期刊介绍:
"Cancer Research and Clinic" is a series of magazines of the Chinese Medical Association under the supervision of the National Health Commission and sponsored by the Chinese Medical Association.
It mainly reflects scientific research results and academic trends in the field of malignant tumors. The main columns include monographs, guidelines and consensus, standards and norms, treatises, short treatises, survey reports, reviews, clinical pathology (case) discussions, case reports, etc. The readers are middle- and senior-level medical staff engaged in basic research and clinical work on malignant tumors.